CIC
DTIL icon

Cornercap Investment Counsel’s Precision BioSciences DTIL Stock Holding History

Cornercap Investment Counsel’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,476
Closed -$101K – 598
2023
Q1 		$101K Hold
4,476
– – 0.02% 536
2022
Q4 		$160K Buy
4,476
+43
+1% +$1.7K 0.03% 523
2022
Q3 		$173K Buy
4,433
+2,003
+82% +$95.2K 0.03% 504
2022
Q2 		$117K Buy
+2,430
New +$143K 0.02% 524

Other funds holding DTIL

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Cornercap Investment Counsel's DTIL Position: Q2 2023 in Review

Cornercap Investment Counsel sold out of Precision BioSciences (DTIL) in Q2 2023, closing a stake of 4,476 shares — an estimated $101K sold.

Cornercap Investment Counsel first reported a position in DTIL in Q2 2022 and held it in 4 quarters. The position peaked at $173K in Q3 2022. 77 funds tracked by Wall St. Rank hold DTIL as of Q2 2023.

  • Cornercap Investment Counsel reported no remaining Precision BioSciences position as of Q2 2023 after selling out during the quarter.
  • Cornercap Investment Counsel sold 4,476 Precision BioSciences shares in Q2 2023, an estimated $101K.
  • Cornercap Investment Counsel first reported a position in Precision BioSciences in Q2 2022 and held it in 4 quarters.
  • Cornercap Investment Counsel's Precision BioSciences position peaked at $173K in Q3 2022.
  • 77 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2023.

Based on Cornercap Investment Counsel's 13F filing for Q2 2023, filed 11 Aug 2023.